Liver-infiltrating CD8+ lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma-Reference-Cited by-同舟云学术

Liver-infiltrating CD8+ lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma

Published:2015-09-29 Issue:3 Volume:36 Page:434-444
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Ramzan Muhammad¹²,Sturm Nathalie¹²³,Decaens Thomas¹²⁴,Bioulac-Sage Paulette⁵,Bancel Brigitte⁶⁷⁸,Merle Philippe⁷⁸⁹,Tran Van Nhieu Jeanne¹⁰,Slama Rémy¹²,Letoublon Christian¹²¹¹,Zarski Jean-Pierre¹²⁴,Jouvin-Marche Evelyne¹²,Marche Patrice N.¹²⁴,Leroy Vincent¹²⁴

Affiliation:

1. INSERM; Unité 823; Grenoble France

2. Université Grenoble-Alpes; Faculté de Médecine; UMR-S823; Grenoble France

3. Département d'Anatomie et de Cytologie Pathologiques; CHU de Grenoble; Grenoble France

4. Clinique d' Hépatogastroentérologie; pôle DigiDune; CHU de Grenoble; Grenoble France

5. Service d'Anatomie et de Cytologie Pathologiques; Hôpital Pellegrin; Bordeaux France

6. Service de Pathologie; Hôpital de la Croix Rousse; Lyon France

7. Université Claude Bernard Lyon 1; INSERM UMR-S1052; Centre de Recherche en Cancérologie de Lyon; Lyon France

8. Hospices Civils de Lyon; Lyon France

9. Service d'Hépatologie; Hôpital de la Croix-Rousse; Lyon France

10. Département de Pathologie; APHP; Groupe Hospitalier Henri Mondor; Val de Marne; Université Paris Est-Créteil; Créteil France

11. Clinique de Chirurgie Digestive; pôle DIGIDUNE; CHU de Grenoble; Grenoble France

Funder

Institut national de la santé et de la recherche médicale

Agence Nationale de Recherches sur le Sida et les Hepatites Virales

DRRC

CHU Grenoble

“Biotherapic” and “AlphaVac” programs of the “Pôle de Compétitivité Lyon Biopôle”

Ligue Contre le Cancer

Higher Education Commission

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.12927/fullpdf

Reference45 articles.

1. Hepatocellular carcinoma in cirrhosis: incidence and risk factors;Fattovich;Gastroenterology,2004

2. management of hepatocellular carcinoma;EASL-EORTC clinical practice guidelines;J Hepatol,2012

3. A lymphotoxin-driven pathway to hepatocellular carcinoma;Haybaeck;Cancer Cell,2009

4. Immune pathogenesis of hepatocellular carcinoma;Nakamoto;J Exp Med,1998

5. Inflammation and cancer;Coussens;Nature,2002

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low CD8+ Density Variation and R1 Surgical Margin as Independent Predictors of Early Post-Resection Recurrence in HCC Patients Meeting Milan Criteria;Current Oncology;2024-09-10

2. Overall Survival Prediction by Tumor Microenvironment Lymphocyte Distribution in Hepatocellular Carcinoma After Liver Transplantation;Journal of Surgical Research;2024-03

3. Key oncogenic signaling pathways affecting tumor-infiltrating lymphocytes infiltration in hepatocellular carcinoma: basic principles and recent advances;Frontiers in Immunology;2024-02-15

4. Causal associations of BAFF-R on IgD+ CD24- immune cell trait with hepatocellular carcinoma and the mediating role of phenylacetylglutamate levels: a Mendelian randomization study;2024-02-15

5. The molecular mechanism of actions and clinical utilities of tumor infiltrating lymphocytes in gastrointestinal cancers: a comprehensive review and future prospects toward personalized medicine;Frontiers in Immunology;2023-11-24